{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "exchange": "CXE", "shortName": "BioMerieux", "longName": "bioM\u00e9rieux S.A.", "exchangeTimezoneName": "Europe/London", "exchangeTimezoneShortName": "BST", "gmtOffSetMilliseconds": 3600000, "market": "gb_market", "esgPopulated": false, "regularMarketChangePercent": 0.0, "regularMarketPrice": 95.16, "marketState": "CLOSED", "fiftyTwoWeekHighChangePercent": 0.0, "fiftyTwoWeekLow": 92.12, "fiftyTwoWeekHigh": 95.16, "trailingAnnualDividendRate": 0.85, "trailingPE": 24.09114, "trailingAnnualDividendYield": 0.008932324, "epsTrailingTwelveMonths": 3.95, "sharesOutstanding": 117946000, "bookValue": 30.544, "fiftyDayAverage": 93.64, "fiftyDayAverageChange": 1.5200043, "fiftyDayAverageChangePercent": 0.016232425, "twoHundredDayAverage": 93.64, "twoHundredDayAverageChange": 1.5200043, "twoHundredDayAverageChangePercent": 0.016232425, "marketCap": 11572883456, "priceToBook": 3.1155055, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "tradeable": false, "cryptoTradeable": false, "priceHint": 2, "regularMarketChange": 0.0, "regularMarketTime": 1683709243, "regularMarketDayHigh": 95.16, "regularMarketDayRange": "95.16 - 95.16", "regularMarketDayLow": 95.16, "regularMarketVolume": 1, "regularMarketPreviousClose": 95.16, "bid": 94.46, "ask": 0.0, "fullExchangeName": "Cboe UK", "financialCurrency": "EUR", "regularMarketOpen": 95.16, "averageDailyVolume3Month": 76, "averageDailyVolume10Day": 76, "fiftyTwoWeekLowChange": 3.040001, "fiftyTwoWeekLowChangePercent": 0.033000443, "fiftyTwoWeekRange": "92.12 - 95.16", "fiftyTwoWeekHighChange": 0.0, "firstTradeDateMilliseconds": 1682665200000, "symbol": "BIMP.XC"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "376 Chemin De l\u2019Orme", "city": "Marcy l'\u00c9toile", "zip": "69280", "country": "France", "phone": "33 4 78 87 20 00", "fax": "33 4 78 87 20 90", "website": "https://www.biomerieux.com", "industry": "Diagnostics & Research", "industryDisp": "Diagnostics & Research", "sector": "Healthcare", "longBusinessSummary": "bioM\u00e9rieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries. It also provides a suite of software products and services that collect, analyze, and merge various sources of data to make decisions under the BIOM\u00c9RIEUX VISION SUITE name; designs, manufactures, and maintains instruments and software; and designs and manufactures reagents for in vitro diagnostic tests. The company serves clinical and hospital laboratories, physicians, blood banks, vets, and industrial control laboratories. bioM\u00e9rieux S.A. was formerly known as B-D M\u00e9rieux. The company was founded in 1963 and is headquartered in Marcy l'Etoile, France. bioM\u00e9rieux S.A. is a subsidiary of Institut M\u00e9rieux SA.", "fullTimeEmployees": 12557, "companyOfficers": [{"maxAge": 1, "name": "Mr. Alexandre  Merieux", "age": 48, "title": "Chairman & CEO", "yearBorn": 1974, "fiscalYear": 2022, "totalPay": {"raw": 1382520, "fmt": "1.38M", "longFmt": "1,382,520"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Pierre  Boulud", "age": 51, "title": "Chief Operating Officer of Clinical Operations", "yearBorn": 1971, "fiscalYear": 2022, "totalPay": {"raw": 1045497, "fmt": "1.05M", "longFmt": "1,045,497"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Frederic  Beseme", "age": 66, "title": "Head of CSR", "yearBorn": 1956, "fiscalYear": 2022, "totalPay": {"raw": 21986, "fmt": "21.99k", "longFmt": "21,986"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Guillaume  Bouhours", "age": 46, "title": "Exec. VP of Purchasing and Information Systems & CFO", "yearBorn": 1976, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Sylvain  Morgeau", "title": "Investor Relations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Valerie  Leylde", "title": "Exec. VP of HR, Communications & CSR", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Fran\u00e7ois  Lacoste", "title": "Exec. VP of R&D", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Mark  Miller", "title": "Exec. VP of Medical Affairs", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Pierre  Charbonnier", "title": "Exec. VP of Quality, Manufacturing & Supply Chain", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Yasha  Mitrotti", "title": "Exec. VP of Industrial Microbiology", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 5, "boardRisk": 7, "compensationRisk": 10, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}